- Home
- CMU vs STRO Comparison
CMU vs STRO Comparison
Compare CMU & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMU
- STRO
- Stock Information
- Founded
- CMU 1987
- STRO 2003
- Country
- CMU United States
- STRO United States
- Employees
- CMU N/A
- STRO N/A
- Industry
- CMU Investment Managers
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMU Finance
- STRO Health Care
- Exchange
- CMU Nasdaq
- STRO Nasdaq
- Market Cap
- CMU 85.0M
- STRO 74.3M
- IPO Year
- CMU N/A
- STRO 2018
- Fundamental
- Price
- CMU $3.46
- STRO $0.90
- Analyst Decision
- CMU
- STRO Hold
- Analyst Count
- CMU 0
- STRO 7
- Target Price
- CMU N/A
- STRO $1.97
- AVG Volume (30 Days)
- CMU 82.4K
- STRO 523.1K
- Earning Date
- CMU 01-01-0001
- STRO 11-12-2025
- Dividend Yield
- CMU 4.08%
- STRO N/A
- EPS Growth
- CMU N/A
- STRO N/A
- EPS
- CMU 0.07
- STRO N/A
- Revenue
- CMU N/A
- STRO $104,473,000.00
- Revenue This Year
- CMU N/A
- STRO $65.48
- Revenue Next Year
- CMU N/A
- STRO N/A
- P/E Ratio
- CMU $47.57
- STRO N/A
- Revenue Growth
- CMU N/A
- STRO N/A
- 52 Week Low
- CMU $2.78
- STRO $0.52
- 52 Week High
- CMU $3.38
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- CMU 73.68
- STRO 50.46
- Support Level
- CMU $3.42
- STRO $0.83
- Resistance Level
- CMU $3.31
- STRO $1.01
- Average True Range (ATR)
- CMU 0.03
- STRO 0.09
- MACD
- CMU 0.01
- STRO -0.01
- Stochastic Oscillator
- CMU 97.37
- STRO 20.80
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.